ANJALI REDDY: Open Payments
NPI 1861762114 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 50 payments from 12 companies in 2025. Trend: 2023 $877 · 2024 $1,679 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $213 |
| GlaxoSmithKline, LLC. | 10 | $190 |
| Novo Nordisk Inc | 8 | $151 |
| PFIZER INC. | 4 | $95 |
| ABBVIE INC. | 4 | $78 |
| Lilly USA, LLC | 4 | $73 |
| Exact Sciences Corporation | 3 | $70 |
| Amgen Inc. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Lundbeck LLC | 1 | $32 |
Products named: TRELEGY ELLIPTA, FARXIGA, Rybelsus, AIRSUPRA, QULIPTA, Wegovy, REXULTI, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
